Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model.
Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model.
复制标题
DOI:
10.1016/j.ebiom.2023.104762
复制
发表时间:
2023-09
期刊:
影响因子:
11.1
通讯作者:
Serghides, Lena
中科院分区:
文献类型:
--
作者:
Mohan, Haneesha;Nguyen, Jessica;Mackenzie, Ben;Yee, Audrey;Laurette, Evelyn Yukino;Sanghvi, Tanvi;Tejada, Oscar;Dontsova, Valeriya;Leung, Kit-Yi;Goddard, Cameron;De Young, Taylor;Sled, John G.;Greene, Nicholas D. E.;Copp, Andrew J.;Serghides, Lena
Dolutegravir (DTG) is a recommended first-line regimen for all people with Human Immunodeficiency Virus (HIV) infection. Initial findings from Botswana, a country with no folate fortification program, showed an elevated prevalence of neural tube defects (NTDs) with peri-conceptional exposure to DTG. Here we explore whether a low folate diet influences the risk of DTG-associated foetal anomalies in a mouse model. C57BL/6 mice fed a folate-deficient diet for 2 weeks, were mated and then randomly allocated to control (water), or 1xDTG (2.5 mg/kg), or 5xDTG (12.5 mg/kg) both administered orally with 50 mg/kg tenofovir disoproxil fumarate 33.3 mg/kg emtricitabine. Treatment was administered once daily from gestational day (GD) 0.5 to sacrifice (GD15.5). Foetuses were assessed for gross anomalies. Maternal and foetal folate levels were quantified. 313 litters (103 control, 106 1xDTG, 104 5xDTG) were assessed. Viability, placental weight, and foetal weight did not differ between groups. NTDs were only observed in the DTG groups (litter rate: 0% control; 1.0% 1xDTG; 1.3% 5xDTG). Tail, abdominal wall, limb, craniofacial, and bleeding defects all occurred at higher rates in the DTG groups versus control. Compared with our previous findings on DTG usage in folate-replete mouse pregnancies, folate deficiency was associated with higher rates of several defects, including NTDs, but in the DTG groups only. We observed a severe left-right asymmetry phenotype that was more frequent in DTG groups than controls. Maternal folate deficiency may increase the risk for DTG-associated foetal defects. Periconceptional folic acid supplementation could be considered for women with HIV taking DTG during pregnancy, particularly in countries lacking folate fortification programs. This project has been funded by Federal funds from the , , under Contract No. HHSN275201800001I and award #R01HD104553. LS is supported by a Tier 1 and HIV. HM is supported by a Junior Investigator award from the .
登录
查看更多内容
影响因子:
11.1
作者:
Gilmore JC;Hoque MT;Dai W;Mohan H;Dunk C;Serghides L;Bendayan R
通讯作者:
Bendayan R
影响因子:
8.8
作者:
Leung KY;Pai YJ;Chen Q;Santos C;Calvani E;Sudiwala S;Savery D;Ralser M;Gross SS;Copp AJ;Greene NDE
通讯作者:
Greene NDE
影响因子:
3.8
作者:
Cabrera, Robert M.;Souder, Jaclyn P.;Finnell, Richard H.
通讯作者:
Finnell, Richard H.
影响因子:
2.4
作者:
Mahajan, Niraj N.;Mahajan, Kshitija N.;Gaikwad, Nilima L.
通讯作者:
Gaikwad, Nilima L.
影响因子:
5.6
作者:
Finnell, RH;Gould, A;Spiegelstein, O
通讯作者:
Spiegelstein, O